Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
34.03
-0.26 (-0.76%)
At close: Nov 14, 2025, 4:00 PM EST
34.25
+0.22 (0.65%)
After-hours: Nov 14, 2025, 7:40 PM EST
HRMY Employees
Harmony Biosciences Holdings had 268 employees as of December 31, 2024. The number of employees increased by 22 or 8.94% compared to the previous year.
Employees
268
Change (1Y)
22
Growth (1Y)
8.94%
Revenue / Employee
$3,081,881
Profits / Employee
$692,821
Market Cap
1.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | 150 | 0 | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
HRMY News
- 10 days ago - Harmony Biosciences Holdings, Inc. (HRMY) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Harmony Biosciences Reports Strong Q3 2025 Financial Results; Recently Raised 2025 Revenue Guidance to $845-$865M - Business Wire
- 22 days ago - Harmony Biosciences Preannounces Strong Q3 2025 WAKIX Performance; Raises 2025 Revenue Guidance - Business Wire
- 4 weeks ago - 3 Biotech Stocks I Am Accumulating - Seeking Alpha
- 5 weeks ago - Top 3 Health Care Stocks That Are Preparing To Pump In Q4 - Benzinga
- 7 weeks ago - Freeport-McMoRan, Harmony Biosciences, Cohu, And Other Big Stocks Moving Lower On Wednesday - Benzinga
- 7 weeks ago - Harmony Biosciences' genetic disorder drug fails to meet main goal in late-stage trial - Reuters
- 7 weeks ago - Harmony Biosciences Provides Update From Its Phase 3 RECONNECT Study of ZYN002 in Fragile X Syndrome - Business Wire